Sildenafil in Acute Pulmonary Embolism

Sildenafil To Prevent Clot

NCT03199612 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Effects of Oral Sildenafil on Mortality in Adults With PAH

NCT02060487 ·Status: TERMINATED ·Phase: PHASE4

Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension

NCT01365585 ·Status: COMPLETED

Sildenafil in Single Ventricle Patients

NCT01169519 ·Status: COMPLETED ·Phase: PHASE1

Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness

NCT00627965 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension

NCT00155714 ·Status: WITHDRAWN ·Phase: NA

Sildenafil in Heart Failure With Reactive Pulmonary Hypertension

NCT02304705 ·Status: TERMINATED ·Phase: PHASE4

Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication

NCT02832570 ·Status: COMPLETED ·Phase: PHASE3

Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention

NCT03686813 ·Status: COMPLETED ·Phase: PHASE2

Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula

NCT02414204 ·Status: COMPLETED ·Phase: NA

A Randomized Controlled Trial Evaluating Sildenafil Citrate in Relieving Ureteral Stent Related Symptoms

NCT02345980 ·Status: COMPLETED ·Phase: PHASE4

Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH

NCT01726049 ·Status: COMPLETED ·Phase: PHASE3

To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.

NCT00430716 ·Status: TERMINATED ·Phase: PHASE4

Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated Patients

NCT00772135 ·Status: UNKNOWN ·Phase: NA

The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH

NCT00159861 ·Status: COMPLETED ·Phase: PHASE3

Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients

NCT01812434 ·Status: WITHDRAWN ·Phase: NA

A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension

NCT00644605 ·Status: COMPLETED ·Phase: PHASE3

Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease

NCT00862043 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies

NCT01321489 ·Status: UNKNOWN ·Phase: PHASE3

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

NCT00517933 ·Status: COMPLETED ·Phase: PHASE3

PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension

NCT02378649 ·Status: COMPLETED ·Phase: PHASE4

Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm

NCT00454714 ·Status: WITHDRAWN ·Phase: PHASE3

Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?

NCT00334490 ·Status: COMPLETED ·Phase: PHASE2

Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease

NCT00492531 ·Status: TERMINATED ·Phase: PHASE2

To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

NCT00946114 ·Status: COMPLETED